The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical and economic evaluation of trastuzumab for metastatic breast cancer in Brazil: A public health system perspective.
Andre Deeke Sasse
Other Remuneration - Roche
Adriana Camargo Carvalho
No relevant relationships to disclose